Rafferty Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.67M | Buy |
|
|||||
|
2025
Q1 | $6.01M | Sell |
|
|||||
|
2024
Q4 | $7.9M | Sell |
|
|||||
|
2024
Q3 | $11.4M | Sell |
|
|||||
|
2024
Q2 | $14.4M | Buy |
|
|||||
|
2024
Q1 | $9.78M | Sell |
|
|||||
|
2023
Q4 | $22M | Buy |
|
|||||
|
2023
Q3 | $7.27M | Buy |
|
|||||
|
2023
Q2 | $7.32M | Buy |
|
|||||
|
2023
Q1 | $6.73M | Sell |
|
|||||
|
2022
Q4 | $10.3M | Buy |
|
|||||
|
2022
Q3 | $6.16M | Buy |
|
|||||
|
2022
Q2 | $3.8M | Sell |
|
|||||
|
2022
Q1 | $5.25M | Sell |
|
|||||
|
2021
Q4 | $6.66M | Buy |
|
|||||
|
2021
Q3 | $3.77M | Sell |
|
|||||
|
2021
Q2 | $2.45M | Sell |
|
|||||
|
2021
Q1 | $3.4M | Buy |
|
|||||
|
2020
Q4 | $825K | Sell |
|
|||||
|
2020
Q3 | $1.54M | Buy |
|
|||||
|
2020
Q2 | $513K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $509K | Sell |
|
|||||
|
2019
Q3 | $827K | Sell |
|
|||||
|
2019
Q2 | $826K | Buy |
|
|||||
|
2019
Q1 | $394K | Buy |
|